Related Experiment Video
Updated: Jan 29, 2026

09:25
Bioluminescent Orthotopic Model of Pancreatic Cancer Progression
Published on: June 28, 2013
27.5K
Rab25 and RCP in cancer progression
Kyung Hwa Cho1, Hoi Young Lee2
1Department of Pharmacology, College of Medicine, Konyang University, 821 Medical Science Building, 158 Gwanjeodong-ro, Seo-gu, Daejeon, 35365, Republic of Korea.
Archives of Pharmacal Research
|February 15, 2019
Summary
Rab25 and Rab coupling protein (RCP) promote cancer progression by regulating endosome recycling. Understanding their roles is key to developing new cancer therapies targeting this deadly disease.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Cancer invasion and metastasis are primary causes of cancer-related mortality.
- Endosome recycling is crucial for cell function and cancer progression.
- Rab25, a Rab-GTPase, plays a context-dependent role in cancer progression.
Purpose of the Study:
- To review recent advancements in understanding Rab25 and RCP's roles in cancer progression.
- To identify key questions for future research on Rab25 and RCP in cancer.
- To discuss potential therapeutic strategies targeting Rab protein-mediated endosome recycling.
Main Methods:
- Literature review of studies on Rab25 and RCP in cancer.
- Analysis of Rab protein function in endosome recycling pathways.
- Discussion of therapeutic implications for cancer treatment.
Main Results:
- Rab25 and its binding partner RCP enhance cancer invasion and metastasis.
- Endosome recycling by Rab25 and RCP contributes significantly to cancer progression.
- Recent progress highlights the importance of these proteins in metastasis.
Conclusions:
- Rab25 and RCP are critical regulators of endosome recycling, driving cancer progression.
- Further research is needed to fully elucidate the mechanisms of Rab25 and RCP in metastasis.
- Targeting Rab protein-mediated endosome recycling presents a promising therapeutic avenue for cancer treatment.
Related Concept Videos
mTOR Signaling and Cancer Progression
4.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.7K
Tumor Progression
7.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K
Cancer
54.2K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.2K
What is Cancer?
14.4K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
14.4K
Cancer Vaccines
1.0K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.0K

